Improving HIV prevention and testing in cities
The science for the last mile: Enhanced epidemiologic surveillance to accelerate HIV elimination
['FUNDING_CAREER'] · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · NIH-10782495
This study is looking at how HIV spreads in cities like San Francisco to help find better ways to protect vulnerable groups, like women and minorities, by understanding what causes new infections.
Quick facts
| Phase | ['FUNDING_CAREER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO (nih funded) |
| Locations | 1 site (SAN FRANCISCO, UNITED STATES) |
| Trial ID | NIH-10782495 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing the understanding of HIV transmission in urban areas, particularly in cities like San Francisco. By analyzing existing surveillance data alongside new data collection, the project aims to identify the key factors driving ongoing HIV infections, especially among vulnerable populations such as women and minorities. The research employs advanced statistical modeling and machine learning techniques to refine population estimates and uses molecular epidemiology to study the genetic relationships of HIV strains. This comprehensive approach seeks to inform targeted interventions that can effectively reduce HIV incidence.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living in urban areas, particularly those who are women or belong to minority groups disproportionately affected by HIV.
Not a fit: Patients living in rural areas or those not at risk for HIV may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective HIV prevention strategies that specifically address the needs of at-risk populations.
How similar studies have performed: Previous research has shown success in using data-driven approaches to improve public health outcomes in HIV prevention, indicating that this methodology is promising.
Where this research is happening
SAN FRANCISCO, UNITED STATES
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO — SAN FRANCISCO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: WESSON, PAUL DOUGLAS — UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
- Study coordinator: WESSON, PAUL DOUGLAS
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome, Acquired Immunodeficiency Syndrome